vs

Side-by-side financial comparison of Claritev Corp (CTEV) and Doximity, Inc. (DOCS). Click either name above to swap in a different company.

Claritev Corp is the larger business by last-quarter revenue ($246.6M vs $185.1M, roughly 1.3× Doximity, Inc.). Doximity, Inc. runs the higher net margin — 33.3% vs -32.7%, a 65.9% gap on every dollar of revenue. On growth, Doximity, Inc. posted the faster year-over-year revenue change (9.8% vs 6.2%). Over the past eight quarters, Doximity, Inc.'s revenue compounded faster (25.2% CAGR vs 2.5%).

Doximity is an online networking service for medical professionals. Launched in 2010, the platform offers its members curated medical news, telehealth tools, and case collaboration.

CTEV vs DOCS — Head-to-Head

Bigger by revenue
CTEV
CTEV
1.3× larger
CTEV
$246.6M
$185.1M
DOCS
Growing faster (revenue YoY)
DOCS
DOCS
+3.5% gap
DOCS
9.8%
6.2%
CTEV
Higher net margin
DOCS
DOCS
65.9% more per $
DOCS
33.3%
-32.7%
CTEV
Faster 2-yr revenue CAGR
DOCS
DOCS
Annualised
DOCS
25.2%
2.5%
CTEV

Income Statement — Q4 FY2025 vs Q3 FY2026

Metric
CTEV
CTEV
DOCS
DOCS
Revenue
$246.6M
$185.1M
Net Profit
$-80.6M
$61.6M
Gross Margin
89.9%
Operating Margin
-3.1%
38.9%
Net Margin
-32.7%
33.3%
Revenue YoY
6.2%
9.8%
Net Profit YoY
41.6%
-18.1%
EPS (diluted)
$-4.88
$0.31

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CTEV
CTEV
DOCS
DOCS
Q4 25
$246.6M
$185.1M
Q3 25
$246.0M
$168.5M
Q2 25
$241.6M
$145.9M
Q1 25
$231.3M
$138.3M
Q4 24
$232.1M
$168.6M
Q3 24
$230.5M
$136.8M
Q2 24
$233.5M
$126.7M
Q1 24
$234.5M
$118.1M
Net Profit
CTEV
CTEV
DOCS
DOCS
Q4 25
$-80.6M
$61.6M
Q3 25
$-69.8M
$62.1M
Q2 25
$-62.6M
$53.3M
Q1 25
$-71.3M
$62.5M
Q4 24
$-138.0M
$75.2M
Q3 24
$-391.4M
$44.2M
Q2 24
$-576.7M
$41.4M
Q1 24
$-539.7M
$40.6M
Gross Margin
CTEV
CTEV
DOCS
DOCS
Q4 25
89.9%
Q3 25
90.3%
Q2 25
89.2%
Q1 25
89.5%
Q4 24
91.6%
Q3 24
90.0%
Q2 24
89.3%
Q1 24
89.4%
Operating Margin
CTEV
CTEV
DOCS
DOCS
Q4 25
-3.1%
38.9%
Q3 25
4.1%
37.8%
Q2 25
6.9%
37.4%
Q1 25
4.2%
35.2%
Q4 24
-17.8%
47.4%
Q3 24
-146.7%
38.8%
Q2 24
-224.4%
36.4%
Q1 24
-207.4%
35.5%
Net Margin
CTEV
CTEV
DOCS
DOCS
Q4 25
-32.7%
33.3%
Q3 25
-28.4%
36.8%
Q2 25
-25.9%
36.5%
Q1 25
-30.8%
45.2%
Q4 24
-59.4%
44.6%
Q3 24
-169.8%
32.3%
Q2 24
-247.0%
32.7%
Q1 24
-230.1%
34.4%
EPS (diluted)
CTEV
CTEV
DOCS
DOCS
Q4 25
$-4.88
$0.31
Q3 25
$-4.23
$0.31
Q2 25
$-3.81
$0.27
Q1 25
$-4.38
$0.31
Q4 24
$-8.49
$0.37
Q3 24
$-24.25
$0.22
Q2 24
$-35.78
$0.21
Q1 24
$-33.40
$0.20

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CTEV
CTEV
DOCS
DOCS
Cash + ST InvestmentsLiquidity on hand
$16.8M
$64.8M
Total DebtLower is stronger
$4.6B
Stockholders' EquityBook value
$-173.9M
$979.3M
Total Assets
$4.9B
$1.2B
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CTEV
CTEV
DOCS
DOCS
Q4 25
$16.8M
$64.8M
Q3 25
$39.2M
$169.2M
Q2 25
$56.4M
$137.3M
Q1 25
$23.1M
$209.6M
Q4 24
$16.8M
$165.3M
Q3 24
$86.6M
$184.2M
Q2 24
$48.8M
$111.4M
Q1 24
$58.7M
$96.8M
Total Debt
CTEV
CTEV
DOCS
DOCS
Q4 25
$4.6B
Q3 25
$4.5B
Q2 25
$4.5B
Q1 25
$4.5B
Q4 24
$4.5B
Q3 24
$4.5B
Q2 24
$4.5B
Q1 24
$4.5B
Stockholders' Equity
CTEV
CTEV
DOCS
DOCS
Q4 25
$-173.9M
$979.3M
Q3 25
$-101.8M
$1.1B
Q2 25
$-39.9M
$1.0B
Q1 25
$14.8M
$1.1B
Q4 24
$84.0M
$1.0B
Q3 24
$207.6M
$961.2M
Q2 24
$603.4M
$913.6M
Q1 24
$1.2B
$901.4M
Total Assets
CTEV
CTEV
DOCS
DOCS
Q4 25
$4.9B
$1.2B
Q3 25
$5.0B
$1.3B
Q2 25
$5.1B
$1.2B
Q1 25
$5.1B
$1.3B
Q4 24
$5.2B
$1.2B
Q3 24
$5.3B
$1.1B
Q2 24
$5.7B
$1.1B
Q1 24
$6.4B
$1.1B
Debt / Equity
CTEV
CTEV
DOCS
DOCS
Q4 25
Q3 25
Q2 25
Q1 25
304.87×
Q4 24
53.67×
Q3 24
21.73×
Q2 24
7.48×
Q1 24
3.85×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CTEV
CTEV
DOCS
DOCS
Operating Cash FlowLast quarter
$66.3M
$60.9M
Free Cash FlowOCF − Capex
$36.4M
FCF MarginFCF / Revenue
14.8%
Capex IntensityCapex / Revenue
12.1%
Cash ConversionOCF / Net Profit
0.99×
TTM Free Cash FlowTrailing 4 quarters
$-12.3M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CTEV
CTEV
DOCS
DOCS
Q4 25
$66.3M
$60.9M
Q3 25
$19.9M
$93.9M
Q2 25
$61.2M
$62.1M
Q1 25
$-30.1M
$98.5M
Q4 24
$-33.4M
$65.2M
Q3 24
$72.8M
$68.3M
Q2 24
$18.5M
$41.2M
Q1 24
$49.7M
$63.9M
Free Cash Flow
CTEV
CTEV
DOCS
DOCS
Q4 25
$36.4M
Q3 25
$-16.3M
Q2 25
$36.6M
Q1 25
$-68.9M
Q4 24
$-63.8M
Q3 24
$41.1M
Q2 24
$-7.0M
Q1 24
$19.2M
FCF Margin
CTEV
CTEV
DOCS
DOCS
Q4 25
14.8%
Q3 25
-6.6%
Q2 25
15.2%
Q1 25
-29.8%
Q4 24
-27.5%
Q3 24
17.8%
Q2 24
-3.0%
Q1 24
8.2%
Capex Intensity
CTEV
CTEV
DOCS
DOCS
Q4 25
12.1%
Q3 25
14.7%
Q2 25
10.2%
Q1 25
16.8%
0.0%
Q4 24
13.1%
0.0%
Q3 24
13.8%
0.0%
Q2 24
10.9%
0.0%
Q1 24
13.0%
0.0%
Cash Conversion
CTEV
CTEV
DOCS
DOCS
Q4 25
0.99×
Q3 25
1.51×
Q2 25
1.16×
Q1 25
1.58×
Q4 24
0.87×
Q3 24
1.55×
Q2 24
1.00×
Q1 24
1.57×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

CTEV
CTEV

Segment breakdown not available.

DOCS
DOCS

Subscription$175.4M95%
Service Other$9.7M5%

Related Comparisons